Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France
Objectives Cancer is a growing concern for HIV‐infected people, and screening plays a major role in alleviating the burden it causes. We sought to investigate the levels and determinants of breast cancer screening (BCS) and cervical cancer screening (CCS) in HIV‐infected women as compared with the g...
Gespeichert in:
| Veröffentlicht in: | HIV medicine 2017-03, Vol.18 (3), p.181-195 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 195 |
|---|---|
| container_issue | 3 |
| container_start_page | 181 |
| container_title | HIV medicine |
| container_volume | 18 |
| creator | Mours, P. Sordage, M. Rabier, V. Huguet, D. Barruet, R. Chabrol, A. Jeantils, V. Hessamfar, M. Mercié, P. Paccalin, F. Pertusa, M. C. Vandenhende, M. A. Rogeaux, O. Mortier, E. Lascaux, A. S. Lelièvre, J. D. Melica, G. Buisson, M. Leprêtre, A. Brion, J. P. Pavese, P. Faba, L. Roncato‐Saberan, M. Leautez‐Nainville, S. Froguel, E. Godin‐Collet, C. Roussin‐Bretagne, S. Denes, E. Ducroix‐Roubertou, S. Boibieux, A. Miailhes, P. Chiarello, P. Dhiver, C. Madrid, A. Ménard, A. Orticoni, M. Soavi, M. J. Favier, C. Jacquet, J. M. Le Moing, V Allavena, C. Bonnet, B. Dellamonica, P. Durant, J. Pugliese, P. Sanderson, F. Prazuck, T. Arsac, P. Ahouanto, M. Dia Kotuba, A. Jestin, C. Joly, V. Landgraf, N. Machado, M. Matheron, S. Bani‐Sadr, F. Batisse, D. Buisson, M. Derouineau, J. Gonzalez, G. Badsi, E. Bendenoun, M. Durel, A. Pichon, F. Roudière, L. Samba, M. C. Tubiana, R. Campa, P. Meyohas, M. C. Raguin, G. Balkan, S. Lafaurie, M. Pavie, J. Pintado, C. Ponscarme, D. Bonnard, P. Lebrette, M. G. Ferreyra, M. Saada, M. Perfezou, P. Bord, S. Debab, Y. Gueit, I. Feltgen, K. Joly, C. Khuong, M. A. Daoud, F. Fascia, P. Partisani, M. Priester, M. Zucman, D. Prevoteau du Clary, F. Chauveau, M. Cuzin, L. Tribonnière, X Huleux, T. Valette, M. Viget, N. Escaut, L. Caraux‐Paz, P. |
| description | Objectives
Cancer is a growing concern for HIV‐infected people, and screening plays a major role in alleviating the burden it causes. We sought to investigate the levels and determinants of breast cancer screening (BCS) and cervical cancer screening (CCS) in HIV‐infected women as compared with the general population.
Methods
The Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 study was conducted in 2011 in a national representative sample of 3022 HIV‐infected hospital out‐patients in France. The rates and correlates of BCS and CCS among HIV‐infected women were compared with those in the general population using multivariate Poisson regression models.
Results
The BCS rate during the 2 years preceding the survey interview was 80.7% among HIV‐infected women vs. 89.1% in the general population (P = 0.146). The CCS rate during the preceding 3 years was 88.1% among HIV‐infected women vs. 83.1% in the general population (P = 0.021). During the preceding year, the CCS rate among HIV‐infected women was 76.5%. The barriers to BCS and CCS were a low educational level [BCS: adjusted prevalence rate ratio 0.88; 95% confidence interval (CI) 0.80–0.97; CCS: adjusted prevalence rate ratio 0.91; 95% CI 0.83–0.99], not having supplementary health insurance (CCS: adjusted prevalence rate ratio 0.92; 95% CI 0.86–0.98), an irregular gynaecological follow‐up (BCS: adjusted prevalence rate ratio 0.77; 95% CI 0.64–0.92; CCS: adjusted prevalence rate ratio 0.72; 95% CI 0.64–0.81) and a low CD4 count (BCS: adjusted prevalence rate ratio 0.83; 95% CI 0.71–0.97; CCS: adjusted prevalence rate ratio 0.78; 95% CI 0.63–0.98). The disparities in CCS uptake in terms of age, employment and gynaecological follow‐up were less pronounced among HIV‐infected women than in the general population.
Conclusions
BCS and CCS uptake was not lower among HIV‐infected women than in the general population, but CCS was suboptimal. Specificities in the profile of barriers to screening emerged. |
| doi_str_mv | 10.1111/hiv.12412 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1945716548</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1868332189</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4212-41f1ad9898ad0db3037d3b7b133bcd3c614a8a7992ceb1a7f4b1cca6292eaac03</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EoqVw4AWQJS5wSOuxvUl8RFVLK63EBbhGE2fSdUnsYCdb9cYLIPGMPAne3cIBCeHLjDWfP431M_YSxCnkc7Zx21OQGuQjdgy6rAuQRj3e97qQZSmP2LOUboWAShnxlB3J2pQVGHPMvq9pS0Pi6Dve0UxxdB79nHjoeRsJ07wfWYpbZ3HgFn3uebKRyDt_w5dpxi_EnedX159_fvvhfE92po7fhZE8t2GcMO6ubt7weUP8hjzFbJrCtAw4u-B3jy_jTvycPelxSPTioZ6wT5cXH8-vivWH99fn79aF1RJkoaEH7ExtauxE1yqhqk61VQtKtbZTtgSNNVbGSEstYNXrFqzFUhpJiFaoE_bm4J1i-LpQmpvRJUvDgJ7CkhowelVBudL1_9G6rJWSUJuMvv4LvQ1L9PkjWSjFKu9bQqbeHigbQ0qR-maKbsR434BodnE2Oc5mH2dmXz0Yl3ak7g_5O78MnB2AOzfQ_b9NTQ7noPwFYIyr0Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1920589861</pqid></control><display><type>article</type><title>Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mours, P. ; Sordage, M. ; Rabier, V. ; Huguet, D. ; Barruet, R. ; Chabrol, A. ; Jeantils, V. ; Hessamfar, M. ; Mercié, P. ; Paccalin, F. ; Pertusa, M. C. ; Vandenhende, M. A. ; Rogeaux, O. ; Mortier, E. ; Lascaux, A. S. ; Lelièvre, J. D. ; Melica, G. ; Buisson, M. ; Leprêtre, A. ; Brion, J. P. ; Pavese, P. ; Faba, L. ; Roncato‐Saberan, M. ; Leautez‐Nainville, S. ; Froguel, E. ; Godin‐Collet, C. ; Roussin‐Bretagne, S. ; Denes, E. ; Ducroix‐Roubertou, S. ; Boibieux, A. ; Miailhes, P. ; Chiarello, P. ; Dhiver, C. ; Madrid, A. ; Ménard, A. ; Orticoni, M. ; Soavi, M. J. ; Favier, C. ; Jacquet, J. M. ; Le Moing, V ; Allavena, C. ; Bonnet, B. ; Dellamonica, P. ; Durant, J. ; Pugliese, P. ; Sanderson, F. ; Prazuck, T. ; Arsac, P. ; Ahouanto, M. ; Dia Kotuba, A. ; Jestin, C. ; Joly, V. ; Landgraf, N. ; Machado, M. ; Matheron, S. ; Bani‐Sadr, F. ; Batisse, D. ; Buisson, M. ; Derouineau, J. ; Gonzalez, G. ; Badsi, E. ; Bendenoun, M. ; Durel, A. ; Pichon, F. ; Roudière, L. ; Samba, M. C. ; Tubiana, R. ; Campa, P. ; Meyohas, M. C. ; Raguin, G. ; Balkan, S. ; Lafaurie, M. ; Pavie, J. ; Pintado, C. ; Ponscarme, D. ; Bonnard, P. ; Lebrette, M. G. ; Ferreyra, M. ; Saada, M. ; Perfezou, P. ; Bord, S. ; Debab, Y. ; Gueit, I. ; Feltgen, K. ; Joly, C. ; Khuong, M. A. ; Daoud, F. ; Fascia, P. ; Partisani, M. ; Priester, M. ; Zucman, D. ; Prevoteau du Clary, F. ; Chauveau, M. ; Cuzin, L. ; Tribonnière, X ; Huleux, T. ; Valette, M. ; Viget, N. ; Escaut, L. ; Caraux‐Paz, P.</creator><creatorcontrib>Mours, P. ; Sordage, M. ; Rabier, V. ; Huguet, D. ; Barruet, R. ; Chabrol, A. ; Jeantils, V. ; Hessamfar, M. ; Mercié, P. ; Paccalin, F. ; Pertusa, M. C. ; Vandenhende, M. A. ; Rogeaux, O. ; Mortier, E. ; Lascaux, A. S. ; Lelièvre, J. D. ; Melica, G. ; Buisson, M. ; Leprêtre, A. ; Brion, J. P. ; Pavese, P. ; Faba, L. ; Roncato‐Saberan, M. ; Leautez‐Nainville, S. ; Froguel, E. ; Godin‐Collet, C. ; Roussin‐Bretagne, S. ; Denes, E. ; Ducroix‐Roubertou, S. ; Boibieux, A. ; Miailhes, P. ; Chiarello, P. ; Dhiver, C. ; Madrid, A. ; Ménard, A. ; Orticoni, M. ; Soavi, M. J. ; Favier, C. ; Jacquet, J. M. ; Le Moing, V ; Allavena, C. ; Bonnet, B. ; Dellamonica, P. ; Durant, J. ; Pugliese, P. ; Sanderson, F. ; Prazuck, T. ; Arsac, P. ; Ahouanto, M. ; Dia Kotuba, A. ; Jestin, C. ; Joly, V. ; Landgraf, N. ; Machado, M. ; Matheron, S. ; Bani‐Sadr, F. ; Batisse, D. ; Buisson, M. ; Derouineau, J. ; Gonzalez, G. ; Badsi, E. ; Bendenoun, M. ; Durel, A. ; Pichon, F. ; Roudière, L. ; Samba, M. C. ; Tubiana, R. ; Campa, P. ; Meyohas, M. C. ; Raguin, G. ; Balkan, S. ; Lafaurie, M. ; Pavie, J. ; Pintado, C. ; Ponscarme, D. ; Bonnard, P. ; Lebrette, M. G. ; Ferreyra, M. ; Saada, M. ; Perfezou, P. ; Bord, S. ; Debab, Y. ; Gueit, I. ; Feltgen, K. ; Joly, C. ; Khuong, M. A. ; Daoud, F. ; Fascia, P. ; Partisani, M. ; Priester, M. ; Zucman, D. ; Prevoteau du Clary, F. ; Chauveau, M. ; Cuzin, L. ; Tribonnière, X ; Huleux, T. ; Valette, M. ; Viget, N. ; Escaut, L. ; Caraux‐Paz, P. ; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group ; for the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group</creatorcontrib><description>Objectives
Cancer is a growing concern for HIV‐infected people, and screening plays a major role in alleviating the burden it causes. We sought to investigate the levels and determinants of breast cancer screening (BCS) and cervical cancer screening (CCS) in HIV‐infected women as compared with the general population.
Methods
The Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 study was conducted in 2011 in a national representative sample of 3022 HIV‐infected hospital out‐patients in France. The rates and correlates of BCS and CCS among HIV‐infected women were compared with those in the general population using multivariate Poisson regression models.
Results
The BCS rate during the 2 years preceding the survey interview was 80.7% among HIV‐infected women vs. 89.1% in the general population (P = 0.146). The CCS rate during the preceding 3 years was 88.1% among HIV‐infected women vs. 83.1% in the general population (P = 0.021). During the preceding year, the CCS rate among HIV‐infected women was 76.5%. The barriers to BCS and CCS were a low educational level [BCS: adjusted prevalence rate ratio 0.88; 95% confidence interval (CI) 0.80–0.97; CCS: adjusted prevalence rate ratio 0.91; 95% CI 0.83–0.99], not having supplementary health insurance (CCS: adjusted prevalence rate ratio 0.92; 95% CI 0.86–0.98), an irregular gynaecological follow‐up (BCS: adjusted prevalence rate ratio 0.77; 95% CI 0.64–0.92; CCS: adjusted prevalence rate ratio 0.72; 95% CI 0.64–0.81) and a low CD4 count (BCS: adjusted prevalence rate ratio 0.83; 95% CI 0.71–0.97; CCS: adjusted prevalence rate ratio 0.78; 95% CI 0.63–0.98). The disparities in CCS uptake in terms of age, employment and gynaecological follow‐up were less pronounced among HIV‐infected women than in the general population.
Conclusions
BCS and CCS uptake was not lower among HIV‐infected women than in the general population, but CCS was suboptimal. Specificities in the profile of barriers to screening emerged.</description><identifier>ISSN: 1464-2662</identifier><identifier>EISSN: 1468-1293</identifier><identifier>DOI: 10.1111/hiv.12412</identifier><identifier>PMID: 28967199</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adult ; Age ; Aged ; Antiretroviral drugs ; Breast cancer ; Breast Neoplasms - epidemiology ; Cancer ; Cancer screening ; CD4 antigen ; Cervical cancer ; Cervix ; Confidence intervals ; Early Detection of Cancer ; Female ; France ; France - epidemiology ; Gynecology ; Health risk assessment ; HIV infection ; HIV Infections - complications ; Humans ; Insurance ; Lentivirus ; Linear Models ; Medical screening ; Middle Aged ; Patients ; Population ; Prevalence ; Regression analysis ; Retroviridae ; screening ; Socioeconomic Factors ; Uterine Cervical Neoplasms - epidemiology ; Womens health</subject><ispartof>HIV medicine, 2017-03, Vol.18 (3), p.181-195</ispartof><rights>2016 British HIV Association</rights><rights>2016 British HIV Association.</rights><rights>HIV Medicine © 2017 British HIV Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4212-41f1ad9898ad0db3037d3b7b133bcd3c614a8a7992ceb1a7f4b1cca6292eaac03</citedby><cites>FETCH-LOGICAL-c4212-41f1ad9898ad0db3037d3b7b133bcd3c614a8a7992ceb1a7f4b1cca6292eaac03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhiv.12412$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhiv.12412$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28967199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mours, P.</creatorcontrib><creatorcontrib>Sordage, M.</creatorcontrib><creatorcontrib>Rabier, V.</creatorcontrib><creatorcontrib>Huguet, D.</creatorcontrib><creatorcontrib>Barruet, R.</creatorcontrib><creatorcontrib>Chabrol, A.</creatorcontrib><creatorcontrib>Jeantils, V.</creatorcontrib><creatorcontrib>Hessamfar, M.</creatorcontrib><creatorcontrib>Mercié, P.</creatorcontrib><creatorcontrib>Paccalin, F.</creatorcontrib><creatorcontrib>Pertusa, M. C.</creatorcontrib><creatorcontrib>Vandenhende, M. A.</creatorcontrib><creatorcontrib>Rogeaux, O.</creatorcontrib><creatorcontrib>Mortier, E.</creatorcontrib><creatorcontrib>Lascaux, A. S.</creatorcontrib><creatorcontrib>Lelièvre, J. D.</creatorcontrib><creatorcontrib>Melica, G.</creatorcontrib><creatorcontrib>Buisson, M.</creatorcontrib><creatorcontrib>Leprêtre, A.</creatorcontrib><creatorcontrib>Brion, J. P.</creatorcontrib><creatorcontrib>Pavese, P.</creatorcontrib><creatorcontrib>Faba, L.</creatorcontrib><creatorcontrib>Roncato‐Saberan, M.</creatorcontrib><creatorcontrib>Leautez‐Nainville, S.</creatorcontrib><creatorcontrib>Froguel, E.</creatorcontrib><creatorcontrib>Godin‐Collet, C.</creatorcontrib><creatorcontrib>Roussin‐Bretagne, S.</creatorcontrib><creatorcontrib>Denes, E.</creatorcontrib><creatorcontrib>Ducroix‐Roubertou, S.</creatorcontrib><creatorcontrib>Boibieux, A.</creatorcontrib><creatorcontrib>Miailhes, P.</creatorcontrib><creatorcontrib>Chiarello, P.</creatorcontrib><creatorcontrib>Dhiver, C.</creatorcontrib><creatorcontrib>Madrid, A.</creatorcontrib><creatorcontrib>Ménard, A.</creatorcontrib><creatorcontrib>Orticoni, M.</creatorcontrib><creatorcontrib>Soavi, M. J.</creatorcontrib><creatorcontrib>Favier, C.</creatorcontrib><creatorcontrib>Jacquet, J. M.</creatorcontrib><creatorcontrib>Le Moing, V</creatorcontrib><creatorcontrib>Allavena, C.</creatorcontrib><creatorcontrib>Bonnet, B.</creatorcontrib><creatorcontrib>Dellamonica, P.</creatorcontrib><creatorcontrib>Durant, J.</creatorcontrib><creatorcontrib>Pugliese, P.</creatorcontrib><creatorcontrib>Sanderson, F.</creatorcontrib><creatorcontrib>Prazuck, T.</creatorcontrib><creatorcontrib>Arsac, P.</creatorcontrib><creatorcontrib>Ahouanto, M.</creatorcontrib><creatorcontrib>Dia Kotuba, A.</creatorcontrib><creatorcontrib>Jestin, C.</creatorcontrib><creatorcontrib>Joly, V.</creatorcontrib><creatorcontrib>Landgraf, N.</creatorcontrib><creatorcontrib>Machado, M.</creatorcontrib><creatorcontrib>Matheron, S.</creatorcontrib><creatorcontrib>Bani‐Sadr, F.</creatorcontrib><creatorcontrib>Batisse, D.</creatorcontrib><creatorcontrib>Buisson, M.</creatorcontrib><creatorcontrib>Derouineau, J.</creatorcontrib><creatorcontrib>Gonzalez, G.</creatorcontrib><creatorcontrib>Badsi, E.</creatorcontrib><creatorcontrib>Bendenoun, M.</creatorcontrib><creatorcontrib>Durel, A.</creatorcontrib><creatorcontrib>Pichon, F.</creatorcontrib><creatorcontrib>Roudière, L.</creatorcontrib><creatorcontrib>Samba, M. C.</creatorcontrib><creatorcontrib>Tubiana, R.</creatorcontrib><creatorcontrib>Campa, P.</creatorcontrib><creatorcontrib>Meyohas, M. C.</creatorcontrib><creatorcontrib>Raguin, G.</creatorcontrib><creatorcontrib>Balkan, S.</creatorcontrib><creatorcontrib>Lafaurie, M.</creatorcontrib><creatorcontrib>Pavie, J.</creatorcontrib><creatorcontrib>Pintado, C.</creatorcontrib><creatorcontrib>Ponscarme, D.</creatorcontrib><creatorcontrib>Bonnard, P.</creatorcontrib><creatorcontrib>Lebrette, M. G.</creatorcontrib><creatorcontrib>Ferreyra, M.</creatorcontrib><creatorcontrib>Saada, M.</creatorcontrib><creatorcontrib>Perfezou, P.</creatorcontrib><creatorcontrib>Bord, S.</creatorcontrib><creatorcontrib>Debab, Y.</creatorcontrib><creatorcontrib>Gueit, I.</creatorcontrib><creatorcontrib>Feltgen, K.</creatorcontrib><creatorcontrib>Joly, C.</creatorcontrib><creatorcontrib>Khuong, M. A.</creatorcontrib><creatorcontrib>Daoud, F.</creatorcontrib><creatorcontrib>Fascia, P.</creatorcontrib><creatorcontrib>Partisani, M.</creatorcontrib><creatorcontrib>Priester, M.</creatorcontrib><creatorcontrib>Zucman, D.</creatorcontrib><creatorcontrib>Prevoteau du Clary, F.</creatorcontrib><creatorcontrib>Chauveau, M.</creatorcontrib><creatorcontrib>Cuzin, L.</creatorcontrib><creatorcontrib>Tribonnière, X</creatorcontrib><creatorcontrib>Huleux, T.</creatorcontrib><creatorcontrib>Valette, M.</creatorcontrib><creatorcontrib>Viget, N.</creatorcontrib><creatorcontrib>Escaut, L.</creatorcontrib><creatorcontrib>Caraux‐Paz, P.</creatorcontrib><creatorcontrib>Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group</creatorcontrib><creatorcontrib>for the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group</creatorcontrib><title>Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France</title><title>HIV medicine</title><addtitle>HIV Med</addtitle><description>Objectives
Cancer is a growing concern for HIV‐infected people, and screening plays a major role in alleviating the burden it causes. We sought to investigate the levels and determinants of breast cancer screening (BCS) and cervical cancer screening (CCS) in HIV‐infected women as compared with the general population.
Methods
The Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 study was conducted in 2011 in a national representative sample of 3022 HIV‐infected hospital out‐patients in France. The rates and correlates of BCS and CCS among HIV‐infected women were compared with those in the general population using multivariate Poisson regression models.
Results
The BCS rate during the 2 years preceding the survey interview was 80.7% among HIV‐infected women vs. 89.1% in the general population (P = 0.146). The CCS rate during the preceding 3 years was 88.1% among HIV‐infected women vs. 83.1% in the general population (P = 0.021). During the preceding year, the CCS rate among HIV‐infected women was 76.5%. The barriers to BCS and CCS were a low educational level [BCS: adjusted prevalence rate ratio 0.88; 95% confidence interval (CI) 0.80–0.97; CCS: adjusted prevalence rate ratio 0.91; 95% CI 0.83–0.99], not having supplementary health insurance (CCS: adjusted prevalence rate ratio 0.92; 95% CI 0.86–0.98), an irregular gynaecological follow‐up (BCS: adjusted prevalence rate ratio 0.77; 95% CI 0.64–0.92; CCS: adjusted prevalence rate ratio 0.72; 95% CI 0.64–0.81) and a low CD4 count (BCS: adjusted prevalence rate ratio 0.83; 95% CI 0.71–0.97; CCS: adjusted prevalence rate ratio 0.78; 95% CI 0.63–0.98). The disparities in CCS uptake in terms of age, employment and gynaecological follow‐up were less pronounced among HIV‐infected women than in the general population.
Conclusions
BCS and CCS uptake was not lower among HIV‐infected women than in the general population, but CCS was suboptimal. Specificities in the profile of barriers to screening emerged.</description><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Antiretroviral drugs</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Cancer</subject><subject>Cancer screening</subject><subject>CD4 antigen</subject><subject>Cervical cancer</subject><subject>Cervix</subject><subject>Confidence intervals</subject><subject>Early Detection of Cancer</subject><subject>Female</subject><subject>France</subject><subject>France - epidemiology</subject><subject>Gynecology</subject><subject>Health risk assessment</subject><subject>HIV infection</subject><subject>HIV Infections - complications</subject><subject>Humans</subject><subject>Insurance</subject><subject>Lentivirus</subject><subject>Linear Models</subject><subject>Medical screening</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Population</subject><subject>Prevalence</subject><subject>Regression analysis</subject><subject>Retroviridae</subject><subject>screening</subject><subject>Socioeconomic Factors</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Womens health</subject><issn>1464-2662</issn><issn>1468-1293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EoqVw4AWQJS5wSOuxvUl8RFVLK63EBbhGE2fSdUnsYCdb9cYLIPGMPAne3cIBCeHLjDWfP431M_YSxCnkc7Zx21OQGuQjdgy6rAuQRj3e97qQZSmP2LOUboWAShnxlB3J2pQVGHPMvq9pS0Pi6Dve0UxxdB79nHjoeRsJ07wfWYpbZ3HgFn3uebKRyDt_w5dpxi_EnedX159_fvvhfE92po7fhZE8t2GcMO6ubt7weUP8hjzFbJrCtAw4u-B3jy_jTvycPelxSPTioZ6wT5cXH8-vivWH99fn79aF1RJkoaEH7ExtauxE1yqhqk61VQtKtbZTtgSNNVbGSEstYNXrFqzFUhpJiFaoE_bm4J1i-LpQmpvRJUvDgJ7CkhowelVBudL1_9G6rJWSUJuMvv4LvQ1L9PkjWSjFKu9bQqbeHigbQ0qR-maKbsR434BodnE2Oc5mH2dmXz0Yl3ak7g_5O78MnB2AOzfQ_b9NTQ7noPwFYIyr0Q</recordid><startdate>201703</startdate><enddate>201703</enddate><creator>Mours, P.</creator><creator>Sordage, M.</creator><creator>Rabier, V.</creator><creator>Huguet, D.</creator><creator>Barruet, R.</creator><creator>Chabrol, A.</creator><creator>Jeantils, V.</creator><creator>Hessamfar, M.</creator><creator>Mercié, P.</creator><creator>Paccalin, F.</creator><creator>Pertusa, M. C.</creator><creator>Vandenhende, M. A.</creator><creator>Rogeaux, O.</creator><creator>Mortier, E.</creator><creator>Lascaux, A. S.</creator><creator>Lelièvre, J. D.</creator><creator>Melica, G.</creator><creator>Buisson, M.</creator><creator>Leprêtre, A.</creator><creator>Brion, J. P.</creator><creator>Pavese, P.</creator><creator>Faba, L.</creator><creator>Roncato‐Saberan, M.</creator><creator>Leautez‐Nainville, S.</creator><creator>Froguel, E.</creator><creator>Godin‐Collet, C.</creator><creator>Roussin‐Bretagne, S.</creator><creator>Denes, E.</creator><creator>Ducroix‐Roubertou, S.</creator><creator>Boibieux, A.</creator><creator>Miailhes, P.</creator><creator>Chiarello, P.</creator><creator>Dhiver, C.</creator><creator>Madrid, A.</creator><creator>Ménard, A.</creator><creator>Orticoni, M.</creator><creator>Soavi, M. J.</creator><creator>Favier, C.</creator><creator>Jacquet, J. M.</creator><creator>Le Moing, V</creator><creator>Allavena, C.</creator><creator>Bonnet, B.</creator><creator>Dellamonica, P.</creator><creator>Durant, J.</creator><creator>Pugliese, P.</creator><creator>Sanderson, F.</creator><creator>Prazuck, T.</creator><creator>Arsac, P.</creator><creator>Ahouanto, M.</creator><creator>Dia Kotuba, A.</creator><creator>Jestin, C.</creator><creator>Joly, V.</creator><creator>Landgraf, N.</creator><creator>Machado, M.</creator><creator>Matheron, S.</creator><creator>Bani‐Sadr, F.</creator><creator>Batisse, D.</creator><creator>Buisson, M.</creator><creator>Derouineau, J.</creator><creator>Gonzalez, G.</creator><creator>Badsi, E.</creator><creator>Bendenoun, M.</creator><creator>Durel, A.</creator><creator>Pichon, F.</creator><creator>Roudière, L.</creator><creator>Samba, M. C.</creator><creator>Tubiana, R.</creator><creator>Campa, P.</creator><creator>Meyohas, M. C.</creator><creator>Raguin, G.</creator><creator>Balkan, S.</creator><creator>Lafaurie, M.</creator><creator>Pavie, J.</creator><creator>Pintado, C.</creator><creator>Ponscarme, D.</creator><creator>Bonnard, P.</creator><creator>Lebrette, M. G.</creator><creator>Ferreyra, M.</creator><creator>Saada, M.</creator><creator>Perfezou, P.</creator><creator>Bord, S.</creator><creator>Debab, Y.</creator><creator>Gueit, I.</creator><creator>Feltgen, K.</creator><creator>Joly, C.</creator><creator>Khuong, M. A.</creator><creator>Daoud, F.</creator><creator>Fascia, P.</creator><creator>Partisani, M.</creator><creator>Priester, M.</creator><creator>Zucman, D.</creator><creator>Prevoteau du Clary, F.</creator><creator>Chauveau, M.</creator><creator>Cuzin, L.</creator><creator>Tribonnière, X</creator><creator>Huleux, T.</creator><creator>Valette, M.</creator><creator>Viget, N.</creator><creator>Escaut, L.</creator><creator>Caraux‐Paz, P.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201703</creationdate><title>Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France</title><author>Mours, P. ; Sordage, M. ; Rabier, V. ; Huguet, D. ; Barruet, R. ; Chabrol, A. ; Jeantils, V. ; Hessamfar, M. ; Mercié, P. ; Paccalin, F. ; Pertusa, M. C. ; Vandenhende, M. A. ; Rogeaux, O. ; Mortier, E. ; Lascaux, A. S. ; Lelièvre, J. D. ; Melica, G. ; Buisson, M. ; Leprêtre, A. ; Brion, J. P. ; Pavese, P. ; Faba, L. ; Roncato‐Saberan, M. ; Leautez‐Nainville, S. ; Froguel, E. ; Godin‐Collet, C. ; Roussin‐Bretagne, S. ; Denes, E. ; Ducroix‐Roubertou, S. ; Boibieux, A. ; Miailhes, P. ; Chiarello, P. ; Dhiver, C. ; Madrid, A. ; Ménard, A. ; Orticoni, M. ; Soavi, M. J. ; Favier, C. ; Jacquet, J. M. ; Le Moing, V ; Allavena, C. ; Bonnet, B. ; Dellamonica, P. ; Durant, J. ; Pugliese, P. ; Sanderson, F. ; Prazuck, T. ; Arsac, P. ; Ahouanto, M. ; Dia Kotuba, A. ; Jestin, C. ; Joly, V. ; Landgraf, N. ; Machado, M. ; Matheron, S. ; Bani‐Sadr, F. ; Batisse, D. ; Buisson, M. ; Derouineau, J. ; Gonzalez, G. ; Badsi, E. ; Bendenoun, M. ; Durel, A. ; Pichon, F. ; Roudière, L. ; Samba, M. C. ; Tubiana, R. ; Campa, P. ; Meyohas, M. C. ; Raguin, G. ; Balkan, S. ; Lafaurie, M. ; Pavie, J. ; Pintado, C. ; Ponscarme, D. ; Bonnard, P. ; Lebrette, M. G. ; Ferreyra, M. ; Saada, M. ; Perfezou, P. ; Bord, S. ; Debab, Y. ; Gueit, I. ; Feltgen, K. ; Joly, C. ; Khuong, M. A. ; Daoud, F. ; Fascia, P. ; Partisani, M. ; Priester, M. ; Zucman, D. ; Prevoteau du Clary, F. ; Chauveau, M. ; Cuzin, L. ; Tribonnière, X ; Huleux, T. ; Valette, M. ; Viget, N. ; Escaut, L. ; Caraux‐Paz, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4212-41f1ad9898ad0db3037d3b7b133bcd3c614a8a7992ceb1a7f4b1cca6292eaac03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Antiretroviral drugs</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Cancer</topic><topic>Cancer screening</topic><topic>CD4 antigen</topic><topic>Cervical cancer</topic><topic>Cervix</topic><topic>Confidence intervals</topic><topic>Early Detection of Cancer</topic><topic>Female</topic><topic>France</topic><topic>France - epidemiology</topic><topic>Gynecology</topic><topic>Health risk assessment</topic><topic>HIV infection</topic><topic>HIV Infections - complications</topic><topic>Humans</topic><topic>Insurance</topic><topic>Lentivirus</topic><topic>Linear Models</topic><topic>Medical screening</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Population</topic><topic>Prevalence</topic><topic>Regression analysis</topic><topic>Retroviridae</topic><topic>screening</topic><topic>Socioeconomic Factors</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mours, P.</creatorcontrib><creatorcontrib>Sordage, M.</creatorcontrib><creatorcontrib>Rabier, V.</creatorcontrib><creatorcontrib>Huguet, D.</creatorcontrib><creatorcontrib>Barruet, R.</creatorcontrib><creatorcontrib>Chabrol, A.</creatorcontrib><creatorcontrib>Jeantils, V.</creatorcontrib><creatorcontrib>Hessamfar, M.</creatorcontrib><creatorcontrib>Mercié, P.</creatorcontrib><creatorcontrib>Paccalin, F.</creatorcontrib><creatorcontrib>Pertusa, M. C.</creatorcontrib><creatorcontrib>Vandenhende, M. A.</creatorcontrib><creatorcontrib>Rogeaux, O.</creatorcontrib><creatorcontrib>Mortier, E.</creatorcontrib><creatorcontrib>Lascaux, A. S.</creatorcontrib><creatorcontrib>Lelièvre, J. D.</creatorcontrib><creatorcontrib>Melica, G.</creatorcontrib><creatorcontrib>Buisson, M.</creatorcontrib><creatorcontrib>Leprêtre, A.</creatorcontrib><creatorcontrib>Brion, J. P.</creatorcontrib><creatorcontrib>Pavese, P.</creatorcontrib><creatorcontrib>Faba, L.</creatorcontrib><creatorcontrib>Roncato‐Saberan, M.</creatorcontrib><creatorcontrib>Leautez‐Nainville, S.</creatorcontrib><creatorcontrib>Froguel, E.</creatorcontrib><creatorcontrib>Godin‐Collet, C.</creatorcontrib><creatorcontrib>Roussin‐Bretagne, S.</creatorcontrib><creatorcontrib>Denes, E.</creatorcontrib><creatorcontrib>Ducroix‐Roubertou, S.</creatorcontrib><creatorcontrib>Boibieux, A.</creatorcontrib><creatorcontrib>Miailhes, P.</creatorcontrib><creatorcontrib>Chiarello, P.</creatorcontrib><creatorcontrib>Dhiver, C.</creatorcontrib><creatorcontrib>Madrid, A.</creatorcontrib><creatorcontrib>Ménard, A.</creatorcontrib><creatorcontrib>Orticoni, M.</creatorcontrib><creatorcontrib>Soavi, M. J.</creatorcontrib><creatorcontrib>Favier, C.</creatorcontrib><creatorcontrib>Jacquet, J. M.</creatorcontrib><creatorcontrib>Le Moing, V</creatorcontrib><creatorcontrib>Allavena, C.</creatorcontrib><creatorcontrib>Bonnet, B.</creatorcontrib><creatorcontrib>Dellamonica, P.</creatorcontrib><creatorcontrib>Durant, J.</creatorcontrib><creatorcontrib>Pugliese, P.</creatorcontrib><creatorcontrib>Sanderson, F.</creatorcontrib><creatorcontrib>Prazuck, T.</creatorcontrib><creatorcontrib>Arsac, P.</creatorcontrib><creatorcontrib>Ahouanto, M.</creatorcontrib><creatorcontrib>Dia Kotuba, A.</creatorcontrib><creatorcontrib>Jestin, C.</creatorcontrib><creatorcontrib>Joly, V.</creatorcontrib><creatorcontrib>Landgraf, N.</creatorcontrib><creatorcontrib>Machado, M.</creatorcontrib><creatorcontrib>Matheron, S.</creatorcontrib><creatorcontrib>Bani‐Sadr, F.</creatorcontrib><creatorcontrib>Batisse, D.</creatorcontrib><creatorcontrib>Buisson, M.</creatorcontrib><creatorcontrib>Derouineau, J.</creatorcontrib><creatorcontrib>Gonzalez, G.</creatorcontrib><creatorcontrib>Badsi, E.</creatorcontrib><creatorcontrib>Bendenoun, M.</creatorcontrib><creatorcontrib>Durel, A.</creatorcontrib><creatorcontrib>Pichon, F.</creatorcontrib><creatorcontrib>Roudière, L.</creatorcontrib><creatorcontrib>Samba, M. C.</creatorcontrib><creatorcontrib>Tubiana, R.</creatorcontrib><creatorcontrib>Campa, P.</creatorcontrib><creatorcontrib>Meyohas, M. C.</creatorcontrib><creatorcontrib>Raguin, G.</creatorcontrib><creatorcontrib>Balkan, S.</creatorcontrib><creatorcontrib>Lafaurie, M.</creatorcontrib><creatorcontrib>Pavie, J.</creatorcontrib><creatorcontrib>Pintado, C.</creatorcontrib><creatorcontrib>Ponscarme, D.</creatorcontrib><creatorcontrib>Bonnard, P.</creatorcontrib><creatorcontrib>Lebrette, M. G.</creatorcontrib><creatorcontrib>Ferreyra, M.</creatorcontrib><creatorcontrib>Saada, M.</creatorcontrib><creatorcontrib>Perfezou, P.</creatorcontrib><creatorcontrib>Bord, S.</creatorcontrib><creatorcontrib>Debab, Y.</creatorcontrib><creatorcontrib>Gueit, I.</creatorcontrib><creatorcontrib>Feltgen, K.</creatorcontrib><creatorcontrib>Joly, C.</creatorcontrib><creatorcontrib>Khuong, M. A.</creatorcontrib><creatorcontrib>Daoud, F.</creatorcontrib><creatorcontrib>Fascia, P.</creatorcontrib><creatorcontrib>Partisani, M.</creatorcontrib><creatorcontrib>Priester, M.</creatorcontrib><creatorcontrib>Zucman, D.</creatorcontrib><creatorcontrib>Prevoteau du Clary, F.</creatorcontrib><creatorcontrib>Chauveau, M.</creatorcontrib><creatorcontrib>Cuzin, L.</creatorcontrib><creatorcontrib>Tribonnière, X</creatorcontrib><creatorcontrib>Huleux, T.</creatorcontrib><creatorcontrib>Valette, M.</creatorcontrib><creatorcontrib>Viget, N.</creatorcontrib><creatorcontrib>Escaut, L.</creatorcontrib><creatorcontrib>Caraux‐Paz, P.</creatorcontrib><creatorcontrib>Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group</creatorcontrib><creatorcontrib>for the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>HIV medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mours, P.</au><au>Sordage, M.</au><au>Rabier, V.</au><au>Huguet, D.</au><au>Barruet, R.</au><au>Chabrol, A.</au><au>Jeantils, V.</au><au>Hessamfar, M.</au><au>Mercié, P.</au><au>Paccalin, F.</au><au>Pertusa, M. C.</au><au>Vandenhende, M. A.</au><au>Rogeaux, O.</au><au>Mortier, E.</au><au>Lascaux, A. S.</au><au>Lelièvre, J. D.</au><au>Melica, G.</au><au>Buisson, M.</au><au>Leprêtre, A.</au><au>Brion, J. P.</au><au>Pavese, P.</au><au>Faba, L.</au><au>Roncato‐Saberan, M.</au><au>Leautez‐Nainville, S.</au><au>Froguel, E.</au><au>Godin‐Collet, C.</au><au>Roussin‐Bretagne, S.</au><au>Denes, E.</au><au>Ducroix‐Roubertou, S.</au><au>Boibieux, A.</au><au>Miailhes, P.</au><au>Chiarello, P.</au><au>Dhiver, C.</au><au>Madrid, A.</au><au>Ménard, A.</au><au>Orticoni, M.</au><au>Soavi, M. J.</au><au>Favier, C.</au><au>Jacquet, J. M.</au><au>Le Moing, V</au><au>Allavena, C.</au><au>Bonnet, B.</au><au>Dellamonica, P.</au><au>Durant, J.</au><au>Pugliese, P.</au><au>Sanderson, F.</au><au>Prazuck, T.</au><au>Arsac, P.</au><au>Ahouanto, M.</au><au>Dia Kotuba, A.</au><au>Jestin, C.</au><au>Joly, V.</au><au>Landgraf, N.</au><au>Machado, M.</au><au>Matheron, S.</au><au>Bani‐Sadr, F.</au><au>Batisse, D.</au><au>Buisson, M.</au><au>Derouineau, J.</au><au>Gonzalez, G.</au><au>Badsi, E.</au><au>Bendenoun, M.</au><au>Durel, A.</au><au>Pichon, F.</au><au>Roudière, L.</au><au>Samba, M. C.</au><au>Tubiana, R.</au><au>Campa, P.</au><au>Meyohas, M. C.</au><au>Raguin, G.</au><au>Balkan, S.</au><au>Lafaurie, M.</au><au>Pavie, J.</au><au>Pintado, C.</au><au>Ponscarme, D.</au><au>Bonnard, P.</au><au>Lebrette, M. G.</au><au>Ferreyra, M.</au><au>Saada, M.</au><au>Perfezou, P.</au><au>Bord, S.</au><au>Debab, Y.</au><au>Gueit, I.</au><au>Feltgen, K.</au><au>Joly, C.</au><au>Khuong, M. A.</au><au>Daoud, F.</au><au>Fascia, P.</au><au>Partisani, M.</au><au>Priester, M.</au><au>Zucman, D.</au><au>Prevoteau du Clary, F.</au><au>Chauveau, M.</au><au>Cuzin, L.</au><au>Tribonnière, X</au><au>Huleux, T.</au><au>Valette, M.</au><au>Viget, N.</au><au>Escaut, L.</au><au>Caraux‐Paz, P.</au><aucorp>Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group</aucorp><aucorp>for the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France</atitle><jtitle>HIV medicine</jtitle><addtitle>HIV Med</addtitle><date>2017-03</date><risdate>2017</risdate><volume>18</volume><issue>3</issue><spage>181</spage><epage>195</epage><pages>181-195</pages><issn>1464-2662</issn><eissn>1468-1293</eissn><abstract>Objectives
Cancer is a growing concern for HIV‐infected people, and screening plays a major role in alleviating the burden it causes. We sought to investigate the levels and determinants of breast cancer screening (BCS) and cervical cancer screening (CCS) in HIV‐infected women as compared with the general population.
Methods
The Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 study was conducted in 2011 in a national representative sample of 3022 HIV‐infected hospital out‐patients in France. The rates and correlates of BCS and CCS among HIV‐infected women were compared with those in the general population using multivariate Poisson regression models.
Results
The BCS rate during the 2 years preceding the survey interview was 80.7% among HIV‐infected women vs. 89.1% in the general population (P = 0.146). The CCS rate during the preceding 3 years was 88.1% among HIV‐infected women vs. 83.1% in the general population (P = 0.021). During the preceding year, the CCS rate among HIV‐infected women was 76.5%. The barriers to BCS and CCS were a low educational level [BCS: adjusted prevalence rate ratio 0.88; 95% confidence interval (CI) 0.80–0.97; CCS: adjusted prevalence rate ratio 0.91; 95% CI 0.83–0.99], not having supplementary health insurance (CCS: adjusted prevalence rate ratio 0.92; 95% CI 0.86–0.98), an irregular gynaecological follow‐up (BCS: adjusted prevalence rate ratio 0.77; 95% CI 0.64–0.92; CCS: adjusted prevalence rate ratio 0.72; 95% CI 0.64–0.81) and a low CD4 count (BCS: adjusted prevalence rate ratio 0.83; 95% CI 0.71–0.97; CCS: adjusted prevalence rate ratio 0.78; 95% CI 0.63–0.98). The disparities in CCS uptake in terms of age, employment and gynaecological follow‐up were less pronounced among HIV‐infected women than in the general population.
Conclusions
BCS and CCS uptake was not lower among HIV‐infected women than in the general population, but CCS was suboptimal. Specificities in the profile of barriers to screening emerged.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28967199</pmid><doi>10.1111/hiv.12412</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1464-2662 |
| ispartof | HIV medicine, 2017-03, Vol.18 (3), p.181-195 |
| issn | 1464-2662 1468-1293 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1945716548 |
| source | Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Age Aged Antiretroviral drugs Breast cancer Breast Neoplasms - epidemiology Cancer Cancer screening CD4 antigen Cervical cancer Cervix Confidence intervals Early Detection of Cancer Female France France - epidemiology Gynecology Health risk assessment HIV infection HIV Infections - complications Humans Insurance Lentivirus Linear Models Medical screening Middle Aged Patients Population Prevalence Regression analysis Retroviridae screening Socioeconomic Factors Uterine Cervical Neoplasms - epidemiology Womens health |
| title | Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T23%3A45%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Levels%20and%20determinants%20of%20breast%20and%20cervical%20cancer%20screening%20uptake%20in%20HIV%E2%80%90infected%20women%20compared%20with%20the%20general%20population%20in%20France&rft.jtitle=HIV%20medicine&rft.au=Mours,%20P.&rft.aucorp=Agence%20Nationale%20de%20Recherche%20sur%20le%20Sida%20et%20les%20H%C3%A9patites%20Virales%20(ANRS)%E2%80%90Vespa2%20Study%20Group&rft.date=2017-03&rft.volume=18&rft.issue=3&rft.spage=181&rft.epage=195&rft.pages=181-195&rft.issn=1464-2662&rft.eissn=1468-1293&rft_id=info:doi/10.1111/hiv.12412&rft_dat=%3Cproquest_cross%3E1868332189%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1920589861&rft_id=info:pmid/28967199&rfr_iscdi=true |